BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-8.9%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$482M
AUM Growth
+$482M
(-24%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
78.28%
Holding
34
New
5
Increased
8
Reduced
7
Closed
2
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$15.7M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$15.2M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$14.6M |
| 4 |
ProQR Therapeutics
PRQR
|
$9.44M |
| 5 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$8.75M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$46.8M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$36.9M |
| 3 |
Exelixis
EXEL
|
$3.39M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$3M |
| 5 |
BIND
BIND THERAPEUTICS INC
BIND
|
$1.53M |
Sector Composition
| 1 | Healthcare | 65.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $72.5M | 15.06% | 5,597,065 -3,611,844 | -39% | -$46.8M |
|
|
RCPT
2
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $71.2M | 14.78% | 1,146,300 +235,700 | +26% | +$14.6M |
|
|
3
Ligand Pharmaceuticals
LGND
$3.15B
| $52.1M | 10.82% | 1,108,763 -784,360 | -41% | -$36.9M |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $49.5M | 10.29% | 13,876,513 -839,273 | -6% | -$3M |
|
|
CCXI
5
DELISTED
ChemoCentryx, Inc.
CCXI
| $38.7M | 8.03% | 8,596,772 +414,956 | +5% | +$1.87M |
|
|
OMED
6
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $24.4M | 5.06% | 1,287,847 +462,200 | +56% | +$8.75M |
|
|
CASC
7
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $18.9M | 3.93% | 9,867,278 +9,000 | +0.1% | +$17.3K |
|
|
FPRX
8
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $17.1M | 3.56% | 1,461,900 +208,900 | +17% | +$2.45M |
|
9
Gyre Therapeutics
GYRE
$703M
| $16.8M | 3.5% | 6,655,128 | – | – |
|
|
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
| $15.7M | 3.25% | +1,192,202 | New | +$15.7M |
|
|
CNCE
11
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $15.2M | 3.16% | +1,206,459 | New | +$15.2M |
|
|
QLTI
12
DELISTED
QLT Inc
QLTI
| $9.46M | 1.96% | 2,093,563 -276,700 | -12% | -$1.25M |
|
|
13
ProQR Therapeutics
PRQR
$237M
| $9.44M | 1.96% | +549,000 | New | +$9.44M |
|
|
TRVN
14
DELISTED
Trevena, Inc.
TRVN
| $7.18M | 1.49% | 1,118,743 | – | – |
|
15
Ardelyx
ARDX
$1.53B
| $6.45M | 1.34% | +453,541 | New | +$6.45M |
|
16
Cytokinetics
CYTK
$4.23B
| $5.38M | 1.12% | 1,527,000 +210,000 | +16% | +$739K |
|
|
VTAE
17
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $5.08M | 1.06% | +666,000 | New | +$5.08M |
|
|
ARQL
18
DELISTED
Arqule Inc
ARQL
| $4.82M | 1% | 4,300,887 +1,176,000 | +38% | +$1.32M |
|
|
TBRA
19
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $2.95M | 0.61% | 2,607,091 | – | – |
|
|
BLRX
20
BioLineRX
BLRX
$16.2M
| $2.31M | 0.48% | 1,501,000 | – | – |
|
|
KBIO
21
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $1.8M | 0.37% | 1,162,000 | – | – |
|
22
Achieve Life Sciences
ACHV
$152M
| $1.77M | 0.37% | 662,069 -200,000 | -23% | -$534K |
|
|
SPHS
23
DELISTED
Sophiris Bio, Inc.
SPHS
| $1.76M | 0.37% | 600,000 | – | – |
|
|
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
| $1.26M | 0.26% | 184,999 | – | – |
|
|
AKAO
25
DELISTED
Achaogen, Inc.
AKAO
| $1.22M | 0.25% | 136,600 +11,600 | +9% | +$104K |
|